Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SHR9146 |
| Trade Name | |
| Synonyms | SHR 9146|SHR-9146|HTI-1090|HTI 1090|HTI1090 |
| Drug Descriptions |
SHR9146 inhibits IDO1, which may block immune suppression in tumor microenvironment and enhance antitumor immune response (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 3101-3101). |
| DrugClasses | IDO1 Inhibitor 13 |
| CAS Registry Number | NA |
| NCIT ID | C151945 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Camrelizumab + Rivoceranib + SHR9146 | Camrelizumab Rivoceranib SHR9146 | 0 | 0 |
| Camrelizumab + SHR9146 | Camrelizumab SHR9146 | 0 | 0 |
| SHR9146 | SHR9146 | 0 | 0 |